![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial
The PI3K/AKT/mTOR pathway is an oncogenic driver in breast cancer (BC). In this multi-center, pre-surgical study, we evaluated the tissue effects of the AKT inhibitor MK-2206 in women with stage I–III BC.
-
Article
Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial
Reverse Phase Protein Array (RPPA) is a high-throughput antibody-based technique to assess cellular protein activity. The goal of this study was to assess protein marker changes by RPPA in tumor tissue from a ...
-
Article
Open AccessReproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
Oestrogen receptor (ER)- and progesterone receptor (PR)-negative (ER−PR−) breast cancer is associated with poorer prognosis compared with other breast cancer subtypes. High parity has been associated with an i...
-
Article
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer
Carcinoma is an altered state of tissue differentiation in which epithelial cells no longer respond to cues that keep them in their proper position. A break down in these cues has disastrous consequences not o...
-
Article
Incidence and clinical significance of lymph node metastasis detected by imuno-histochemical stain in DCIS